| Medical and Health Sciences | Lifetime | 537 | US 290 | 99.98 |
| Pharmacology | Lifetime | 9 | US 7 | 99.90 |
| Anesthesiology and Pain Medicine | Lifetime | 16 | US 12 | 99.66 |
| Pediatrics, Perinatology and Child Health | Lifetime | 94 | US 44 | 99.70 |
| Clinical Pharmacology | Lifetime | 76 | US 36 | 99.68 |
| Psychiatry and Mental health | Lifetime | 139 | US 67 | 99.59 |
| Cognitive Psychology | Lifetime | 321 | US 167 | 99.04 |
| Analytical Chemistry | Lifetime | 113 | US 18 | 98.65 |
| Emergency Medicine | Lifetime | 175 | US 94 | 98.62 |
| Cellular and Molecular Neuroscience | Lifetime | 396 | US 216 | 98.56 |
| Oncology | Lifetime | 752 | US 419 | 98.43 |
| Cognitive Neuroscience | Lifetime | 877 | US 450 | 97.65 |
| Geriatrics and Gerontology | Lifetime | 247 | US 104 | 93.94 |
| Toxicology | Lifetime | 183 | US 46 | 91.57 |
| Nephrology | Lifetime | 984 | US 435 | 80.68 |
| Analytical Methods in Pharmaceuticals | Lifetime | 1 | US 1 | 99.86 |
| Anesthesia and Sedative Agents | Lifetime | 6 | US 6 | 99.89 |
| Pharmaceutical studies and practices | Lifetime | 8 | US 6 | 99.81 |
| Pharmacogenetics and Drug Metabolism | Lifetime | 10 | US 6 | 99.79 |
| Epilepsy research and treatment | Lifetime | 27 | US 10 | 99.77 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 34 | US 12 | 99.70 |
| Drug Transport and Resistance Mechanisms | Lifetime | 57 | US 26 | 99.62 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 48 | US 23 | 99.67 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 31 | US 15 | 99.62 |
| Poisoning and overdose treatments | Lifetime | 14 | US 3 | 99.40 |
| Pharmacology and Obesity Treatment | Lifetime | 24 | US 16 | 99.47 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 61 | US 29 | 99.06 |
| Sleep and related disorders | Lifetime | 75 | US 43 | 99.13 |
| Neuroscience and Neuropharmacology Research | Lifetime | 494 | US 248 | 99.34 |
| Sleep and Wakefulness Research | Lifetime | 130 | US 71 | 99.00 |
| Potassium and Related Disorders | Lifetime | 47 | US 30 | 98.87 |
| Diet and metabolism studies | Lifetime | 652 | US 284 | 98.87 |
| Treatment of Major Depression | Lifetime | 127 | US 69 | 98.90 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 165 | US 76 | 98.13 |
| Analytical Chemistry and Chromatography | Lifetime | 814 | US 256 | 98.21 |
| HIV/AIDS drug development and treatment | Lifetime | 423 | US 228 | 98.48 |
| Schizophrenia research and treatment | Lifetime | 348 | US 167 | 98.77 |
| Neurotransmitter Receptor Influence on Behavior | Lifetime | 341 | US 191 | 98.55 |
| Inflammatory mediators and NSAID effects | Lifetime | 360 | US 177 | 97.77 |
| Alcoholism and Thiamine Deficiency | Lifetime | 124 | US 71 | 96.25 |
| Forensic Toxicology and Drug Analysis | Lifetime | 177 | US 67 | 97.06 |
| Memory and Neural Mechanisms | Lifetime | 461 | US 251 | 97.59 |
| Electroconvulsive Therapy Studies | Lifetime | 235 | US 109 | 96.34 |
| Electrolyte and hormonal disorders | Lifetime | 763 | US 360 | 94.53 |
| Statistical Methods in Clinical Trials | Lifetime | 527 | US 279 | 94.47 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | Lifetime | 900 | US 433 | 95.49 |
| Bipolar Disorder and Treatment | Lifetime | 928 | US 403 | 95.36 |
| Renal function and acid-base balance | Lifetime | 743 | US 377 | 93.76 |
| Chemical Reactions and Isotopes | Lifetime | 937 | US 442 | 92.45 |
| Pharmacological Effects and Assays | Lifetime | 806 | US 294 | 91.88 |
| Drug-Induced Ocular Toxicity | Lifetime | 692 | US 293 | 70.97 |
| Academic Writing and Publishing | Lifetime | 367 | US 146 | 64.96 |
| Pharmacogenetics and Drug Metabolism | 2021-2025 | 342 | US 108 | 84.28 |
| Statistical Methods in Clinical Trials | 2021-2025 | 876 | US 368 | 69.07 |
| Pharmacology and Obesity Treatment | 2021-2025 | 658 | US 251 | 67.16 |
